• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. PENUMBRA SMART COIL; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. PENUMBRA SMART COIL; HCG, KRD Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thromboembolism (2654)
Event Date 02/22/2022
Event Type  Injury  
Manufacturer Narrative
The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.Potential adverse events in the labeling with the penumbra smart coil system include, but are not limited to, hematoma or hemorrhage at access site of entry, peripheral thromboembolic events, vessel spasm, thrombosis, dissection or perforation, thromboembolic episodes, including death.The product lot number was not provided, therefore, the manufacturing records could not be reviewed.
 
Event Description
The patient was undergoing a coil embolization procedure to treat a ruptured bifurcation aneurysm in the anterior cerebral artery (aca)-anterior communicating artery (acom) using penumbra smart coils (smart coil) and a non-penumbra microcatheter.During the procedure, a smart coil would not advance into the microcatheter; therefore, the smart coil was removed.The physician then successfully placed four smart coils in the target location using the microcatheter.Afterwards, a control angiographic series was performed that indicated that there was a thrombus adjacent to a protruded loop towards a2 and small repletion defects in relation to thromboembolism in the callosomarginal artery.Subsequently, 15 ml of tirofiban intraarterial (ia) and 17 ml intravenous (iv) was administered to the patient, achieving resolution of the repletion defect.The thromboembolism was reported to be a serious adverse event with a probable relationship to the smart coil system and the index procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PENUMBRA SMART COIL
Type of Device
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key13847609
MDR Text Key288807092
Report Number3005168196-2022-00133
Device Sequence Number1
Product Code HCG
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
K160832
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,03/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received02/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age77 YR
Patient SexFemale
-
-